Camille Cohen

Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease

Camille Cohen, Bruno Royer, Vincent Javaugue et al. · Kidney International · 2015 · 134 citations

Hematological Malignancy, Bone Marrow Failure, Autoimmune Disease +8

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study

Florent Joly, Camille Cohen, Vincent Javaugue et al. · Blood · 2018 · 117 citations · Full text

Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study

Virginie Royal, Nelson Leung, Stéphan Troyanov et al. · Blood · 2020 · 87 citations · Full text

Glomerular endothelial cell senescence drives age‐related kidney disease through PAI‐1

Camille Cohen, O. Le Goff, Frédéric Soysouvanh et al. · EMBO Molecular Medicine · 2021 · 69 citations · Full text

Glomerular Disease, Glomerulonephritis, Aging +13

mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases

Simon C. Johnson, Frank Martinez, Alessandro Bitto et al. · Kidney International · 2018 · 57 citations · Full text

Urology, Mitochondrial Transplantation, Mtor Inhibitors +8